id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02846532 | 34:65:treatment | Satisfactory initial post-Fontan transthoracic echocardiographic Screening | 2 | [
"Satisfactory",
"initial",
"post-Fontan",
"transthoracic",
"echocardiographic",
"Screening"
] | [
0,
0,
0,
1,
1,
0
] |
NCT02469857 | 16:35:chronic_disease | a patient with respiratory failure such that an SaO2 of 80% cannot be achieved | 2 | [
"a",
"patient",
"with",
"respiratory",
"failure",
"such",
"that",
"an",
"SaO2",
"of",
"80",
"%",
"can",
"not",
"be",
"achieved"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02437773 | ,8:11:chronic_disease, | Age of OCD onset after 15 years old | 2 | [
"Age",
"of",
"OCD",
"onset",
"after",
"15",
"years",
"old"
] | [
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT01631617 | 1:22:chronic_disease | chronic skin diseases | 2 | [
"chronic",
"skin",
"diseases"
] | [
2,
2,
2
] |
NCT02504866 | 12:32:chronic_disease | History of exercise intolerance | 2 | [
"History",
"of",
"exercise",
"intolerance"
] | [
0,
0,
2,
2
] |
NCT02474173 | 15:30:treatment,35:59:cancer,46:59:cancer,161:177:treatment | Any number of prior therapies for metastatic breast cancer is allowed; patients with weakly estrogen receptor positive breast cancer who received any number of endocrine agents for metastatic breast cancer | 2 | [
"Any",
"number",
"of",
"prior",
"therapies",
"for",
"metastatic",
"breast",
"cancer",
"is",
"allowed",
";",
"patients",
"with",
"weakly",
"estrogen",
"receptor",
"positive",
"breast",
"cancer",
"who",
"received",
"any",
"number",
"of",
"endocrine",
"agents",
"fo... | [
0,
0,
0,
1,
1,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT01898793 | ,25:45:treatment,79:82:cancer,99:102:cancer | More than one course of salvage chemotherapy for primary induction failure or AML relapsing after CR1 (phase II only) | 2 | [
"More",
"than",
"one",
"course",
"of",
"salvage",
"chemotherapy",
"for",
"primary",
"induction",
"failure",
"or",
"AML",
"relapsing",
"after",
"CR1",
"(",
"phase",
"II",
"only",
")"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT03107546 | 1:74:treatment | Previous surgery on the web that requires a subsequent syndactyly release | 2 | [
"Previous",
"surgery",
"on",
"the",
"web",
"that",
"requires",
"a",
"subsequent",
"syndactyly",
"release"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02516696 | 36:52:treatment | Subject is unable to reliably take oral medications | 2 | [
"Subject",
"is",
"unable",
"to",
"reliably",
"take",
"oral",
"medications"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02145260 | 1:13:chronic_disease | Acute stroke | 2 | [
"Acute",
"stroke"
] | [
2,
2
] |
NCT02740595 | 1:16:chronic_disease | Cardiac disease | 2 | [
"Cardiac",
"disease"
] | [
2,
2
] |
NCT03144921 | 47:59:chronic_disease | Exhibit changes in memory as specified on the AD8 dementia screening tool | 2 | [
"Exhibit",
"changes",
"in",
"memory",
"as",
"specified",
"on",
"the",
"AD8",
"dementia",
"screening",
"tool"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT02476409 | 61:70:allergy_name | History of adverse reaction or clinical contraindication to tolvaptan | 2 | [
"History",
"of",
"adverse",
"reaction",
"or",
"clinical",
"contraindication",
"to",
"tolvaptan"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02106988 | 51:63:treatment,65:75:treatment,81:88:treatment | willingness to accept supportive measures such as transfusions, filgrastim, and Epoetin | 2 | [
"willingness",
"to",
"accept",
"supportive",
"measures",
"such",
"as",
"transfusions",
",",
"filgrastim",
",",
"and",
"Epoetin"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1
] |
NCT02543944 | 54:65:allergy_name | report having had a severe adverse reaction to study medications | 2 | [
"report",
"having",
"had",
"a",
"severe",
"adverse",
"reaction",
"to",
"study",
"medications"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
4
] |
NCT02493530 | 1:25:cancer | non-melanoma skin cancer | 2 | [
"non-melanoma",
"skin",
"cancer"
] | [
3,
3,
3
] |
NCT02577549 | 32:37:chronic_disease,, | Not sufficiently overweight or obese, BMI < 27 kg/m2 | 2 | [
"Not",
"sufficiently",
"overweight",
"or",
"obese",
",",
"BMI",
"<",
"27",
"kg/m2"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02408861 | 45:60:cancer | Repeat imaging demonstrates no new sites of bone metastases | 2 | [
"Repeat",
"imaging",
"demonstrates",
"no",
"new",
"sites",
"of",
"bone",
"metastases"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02516241 | 19:42:treatment,80:137:treatment,139:148:treatment,150:160:treatment,165:186:treatment,198:229:treatment,243:268:treatment,272:285:treatment, | Prior exposure to immune-mediated therapy, including but not limited to, other anti cytotoxic T-lymphocyte-associated protein 4 (CTLA 4), anti-PD-1, anti-PD-L1, or anti-PD-L2 antibodies, including therapeutic anticancer vaccines. Prior local intervesical chemotherapy or immunotherapy is allowed if completed at least 28... | 2 | [
"Prior",
"exposure",
"to",
"immune-mediated",
"therapy",
",",
"including",
"but",
"not",
"limited",
"to",
",",
"other",
"anti",
"cytotoxic",
"T-lymphocyte-associated",
"protein",
"4",
"(",
"CTLA",
"4",
")",
",",
"anti-PD-1",
",",
"anti-PD-L1",
",",
"or",
"anti... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01876511 | 28:49:cancer | Patients with MSI positive non-colorectal cancer | 2 | [
"Patients",
"with",
"MSI",
"positive",
"non-colorectal",
"cancer"
] | [
0,
0,
0,
0,
3,
3
] |
NCT03030859 | 16:22:cancer | No evidence of cancer (NED) | 2 | [
"No",
"evidence",
"of",
"cancer",
"(",
"NED",
")"
] | [
0,
0,
0,
3,
0,
0,
0
] |
NCT02334865 | 14:30:treatment,34:65:treatment | Patients had prior autologous or allogeneic stem cell transplant | 2 | [
"Patients",
"had",
"prior",
"autologous",
"or",
"allogeneic",
"stem",
"cell",
"transplant"
] | [
0,
0,
1,
1,
0,
1,
1,
1,
1
] |
NCT02203903 | 20:28:cancer,32:48:cancer,52:66:treatment | Evidence of active leukemia or lymphoma disease by flow cytometry, morphology, or cytogenetic evaluation within the marrow or extramedullary sites | 2 | [
"Evidence",
"of",
"active",
"leukemia",
"or",
"lymphoma",
"disease",
"by",
"flow",
"cytometry",
",",
"morphology",
",",
"or",
"cytogenetic",
"evaluation",
"within",
"the",
"marrow",
"or",
"extramedullary",
"sites"
] | [
0,
0,
0,
3,
0,
3,
3,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02494869 | 10:16:cancer | Invasive cancer diagnosis | 2 | [
"Invasive",
"cancer",
"diagnosis"
] | [
0,
3,
0
] |
NCT02243813 | 45:58:chronic_disease,60:78:chronic_disease,140:164:chronic_disease | Have a first or second-degree relative with Schizophrenia, Psychotic Disorder (unless substance induced or due to a medical condition), or Bipolar I or II Disorder | 2 | [
"Have",
"a",
"first",
"or",
"second-degree",
"relative",
"with",
"Schizophrenia",
",",
"Psychotic",
"Disorder",
"(",
"unless",
"substance",
"induced",
"or",
"due",
"to",
"a",
"medical",
"condition",
")",
",",
"or",
"Bipolar",
"I",
"or",
"II",
"Disorder"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02989597 | 1:21:chronic_disease | Severe heart disease | 2 | [
"Severe",
"heart",
"disease"
] | [
2,
2,
2
] |
NCT02108860 | 36:71:treatment,73:76:treatment,78:81:treatment,83:85:treatment, | Initiation or dose increase of the maintenance immunosuppressive agent (MTX, AZA, MA) within 3 months prior to screening | 2 | [
"Initiation",
"or",
"dose",
"increase",
"of",
"the",
"maintenance",
"immunosuppressive",
"agent",
"(",
"MTX",
",",
"AZA",
",",
"MA",
")",
"within",
"3",
"months",
"prior",
"to",
"screening"
] | [
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00540761 | 1:21:chronic_disease | Kidney insufficiency | 2 | [
"Kidney",
"insufficiency"
] | [
2,
2
] |
NCT02981173 | 1:26:chronic_disease | Axis I psychotic disorder in first degree relative | 2 | [
"Axis",
"I",
"psychotic",
"disorder",
"in",
"first",
"degree",
"relative"
] | [
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02285101 | ,,,41:62:chronic_disease,,,,,,,,,,, | total bilirubin >2.0 mg/dL, evidence of bile duct obstruction, serum albumin <2.5 g/dL, serum ALT or AST >2.5 x upper limit of normal, serum creatinine ≥1.5 mg/dL, ANC ≥1.5 x 109/L, platelets <100 x 109/L, or INR >2.0 | 2 | [
"total",
"bilirubin",
">",
"2.0",
"mg/dL",
",",
"evidence",
"of",
"bile",
"duct",
"obstruction",
",",
"serum",
"albumin",
"<",
"2.5",
"g/dL",
",",
"serum",
"ALT",
"or",
"AST",
">",
"2.5",
"x",
"upper",
"limit",
"of",
"normal",
",",
"serum",
"creatinine",... | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02101736 | 31:51:chronic_disease, | Any other signs indicative of pulmonary hemorrhage within 3 months before the first dose of study treatment | 2 | [
"Any",
"other",
"signs",
"indicative",
"of",
"pulmonary",
"hemorrhage",
"within",
"3",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03007030 | 1:39:chronic_disease | Serious medical or psychiatric illness likely to interfere with participation in this clinical study | 2 | [
"Serious",
"medical",
"or",
"psychiatric",
"illness",
"likely",
"to",
"interfere",
"with",
"participation",
"in",
"this",
"clinical",
"study"
] | [
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02243813 | 90:103:chronic_disease | Current or past history of meeting Diagnostic and Statistics Manual (DSM)-5 criteria for Schizophrenia | 2 | [
"Current",
"or",
"past",
"history",
"of",
"meeting",
"Diagnostic",
"and",
"Statistics",
"Manual",
"(",
"DSM",
")",
"-5",
"criteria",
"for",
"Schizophrenia"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT02312245 | 1:19:cancer,23:41:cancer,43:61:cancer,65:86:cancer | Platinum resistant or refractory ovarian, primary peritoneal or fallopian tube cancer of any subtype | 2 | [
"Platinum",
"resistant",
"or",
"refractory",
"ovarian",
",",
"primary",
"peritoneal",
"or",
"fallopian",
"tube",
"cancer",
"of",
"any",
"subtype"
] | [
3,
3,
0,
3,
3,
0,
3,
3,
0,
3,
3,
3,
0,
0,
0
] |
NCT02194387 | ,20:32:treatment | Less than 3 months post-surgery | 2 | [
"Less",
"than",
"3",
"months",
"post-surgery"
] | [
0,
0,
0,
0,
1
] |
NCT01920061 | 15:19:cancer,44:64:treatment,72:82:cancer | Patients with TNBC with no prior cytotoxic chemotherapy therapy in the metastatic setting | 2 | [
"Patients",
"with",
"TNBC",
"with",
"no",
"prior",
"cytotoxic",
"chemotherapy",
"therapy",
"in",
"the",
"metastatic",
"setting"
] | [
0,
0,
3,
0,
0,
0,
0,
1,
1,
0,
0,
3,
0
] |
NCT01900301 | 57:72:treatment,74:84:treatment,86:106:treatment,108:118:treatment,120:129:treatment,131:139:treatment,141:155:treatment,157:168:treatment,170:179:treatment,181:192:treatment,194:203:treatment,205:214:treatment,216:225:treatment,227:242:treatment,244:251:treatment,253:265:treatment,267:283:treatment,285:292:treatment,2... | Other drugs that will be reasons for exclusion include: antimuscarinics, nifedipine, parasympathomimetics, amantadine, amoxapine, antacids, antidiarrheals, anxiolytics, hypnotics, atomexetine, bupropion, cisapride, clozapine, cyclobenzaprine, digoxin, disopyramide, dronabinol (THC), ethanol, maprotilline, memantine, me... | 2 | [
"Other",
"drugs",
"that",
"will",
"be",
"reasons",
"for",
"exclusion",
"include",
":",
"antimuscarinics",
",",
"nifedipine",
",",
"parasympathomimetics",
",",
"amantadine",
",",
"amoxapine",
",",
"antacids",
",",
"antidiarrheals",
",",
"anxiolytics",
",",
"hypnoti... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1,
0... |
NCT02394535 | 1:23:chronic_disease | malabsorption syndrome | 2 | [
"malabsorption",
"syndrome"
] | [
2,
2
] |
NCT02304458 | 15:25:cancer,35:49:cancer | Patients with CNS tumors or known CNS metastases | 2 | [
"Patients",
"with",
"CNS",
"tumors",
"or",
"known",
"CNS",
"metastases"
] | [
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT02229565 | 11:40:cancer | Suspected malignancy of prostate cancer | 2 | [
"Suspected",
"malignancy",
"of",
"prostate",
"cancer"
] | [
0,
3,
3,
3,
3
] |
NCT02323945 | 23:39:treatment | Undergoing concurrent physical therapy | 2 | [
"Undergoing",
"concurrent",
"physical",
"therapy"
] | [
0,
0,
1,
1
] |
NCT03087799 | 30:33:chronic_disease | Meet diagnostic criteria for IBS | 2 | [
"Meet",
"diagnostic",
"criteria",
"for",
"IBS"
] | [
0,
0,
0,
0,
2
] |
NCT02186418 | 25:34:cancer | Patients with an active malignant disease | 2 | [
"Patients",
"with",
"an",
"active",
"malignant",
"disease"
] | [
0,
0,
0,
0,
3,
0
] |
NCT02358187 | 22:29:treatment,32:39:treatment,42:50:treatment | Growth factors (e.g. Procrit®, Aranesp®, Neulasta®) | 2 | [
"Growth",
"factors",
"(",
"e.g",
".",
"Procrit®",
",",
"Aranesp®",
",",
"Neulasta®",
")"
] | [
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0
] |
NCT01614197 | 1:19:treatment,53:65:chronic_disease,,111:121:treatment,125:143:treatment | Stem Cell Infusion: No evidence of active graft vs. host disease and at least 84 days must have elapsed after transplant or stem cell infusion | 2 | [
"Stem",
"Cell",
"Infusion",
":",
"No",
"evidence",
"of",
"active",
"graft",
"vs.",
"host",
"disease",
"and",
"at",
"least",
"84",
"days",
"must",
"have",
"elapsed",
"after",
"transplant",
"or",
"stem",
"cell",
"infusion"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1
] |
NCT01686373 | ,45:51:chronic_disease | Patients must be greater than 6-months post-stroke | 2 | [
"Patients",
"must",
"be",
"greater",
"than",
"6-months",
"post-stroke"
] | [
0,
0,
0,
0,
0,
0,
2
] |
NCT02527265 | 1:28:chronic_disease,19:28:chronic_disease,,100:109:treatment, | Respiratory tract infection within 30 days before screening or between screening and initiation of treatment period; subject may return 4 weeks after resolution of the infection for rescreening | 2 | [
"Respiratory",
"tract",
"infection",
"within",
"30",
"days",
"before",
"screening",
"or",
"between",
"screening",
"and",
"initiation",
"of",
"treatment",
"period",
";",
"subject",
"may",
"return",
"4",
"weeks",
"after",
"resolution",
"of",
"the",
"infection",
"f... | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02235857 | 21:36:allergy_name,38:45:allergy_name,50:64:allergy_name | Hypersensitivity to dextran sulfate, heparin, or ethylene oxide | 2 | [
"Hypersensitivity",
"to",
"dextran",
"sulfate",
",",
"heparin",
",",
"or",
"ethylene",
"oxide"
] | [
0,
0,
4,
4,
0,
4,
0,
0,
4,
4
] |
NCT02004028 | 18:40:chronic_disease | Known history of malignant hypertension | 2 | [
"Known",
"history",
"of",
"malignant",
"hypertension"
] | [
0,
0,
0,
2,
2
] |
NCT02496208 | 22:43:treatment,72:86:treatment,95:103:treatment,132:140:treatment,144:164:treatment,166:173:treatment,,194:211:treatment,,227:291:treatment | The subject requires concomitant treatment, in therapeutic doses, with anticoagulants such as warfarin or warfarin-related agents, thrombin or factor Xa inhibitors; aspirin (up to 325 mg/day), low-dose warfarin (=< 1 mg/day), prophylactic and therapeutic low molecular weight heparin (LMWH) | 2 | [
"The",
"subject",
"requires",
"concomitant",
"treatment",
",",
"in",
"therapeutic",
"doses",
",",
"with",
"anticoagulants",
"such",
"as",
"warfarin",
"or",
"warfarin-related",
"agents",
",",
"thrombin",
"or",
"factor",
"Xa",
"inhibitors",
";",
"aspirin",
"(",
"u... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02053792 | 20:104:treatment | subjects requiring major non-emergency surgery who have not previously completed a CSL-sponsored rIX-FP lead-in study | 2 | [
"subjects",
"requiring",
"major",
"non-emergency",
"surgery",
"who",
"have",
"not",
"previously",
"completed",
"a",
"CSL-sponsored",
"rIX-FP",
"lead-in",
"study"
] | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT01918644 | 13:41:cancer | early stage invasive carcinoma of breast | 2 | [
"early",
"stage",
"invasive",
"carcinoma",
"of",
"breast"
] | [
0,
0,
3,
3,
3,
3
] |
NCT03061903 | 1:8:chronic_disease,, | Obesity (Body Mass Index (BMI) > 30) | 2 | [
"Obesity",
"(",
"Body",
"Mass",
"Index",
"(",
"BMI",
")",
">",
"30",
")"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02561988 | ,38:64:cancer | at least 1 C-finding attributable to systemic mastocytosis (SM) | 2 | [
"at",
"least",
"1",
"C-finding",
"attributable",
"to",
"systemic",
"mastocytosis",
"(",
"SM",
")"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0
] |
NCT01890590 | 1:48:treatment | Prior upper abdominal external beam irradiation | 2 | [
"Prior",
"upper",
"abdominal",
"external",
"beam",
"irradiation"
] | [
1,
1,
1,
1,
1,
1
] |
NCT01245712 | 30:56:treatment | Treatment plan that includes regional nodal irradiation | 2 | [
"Treatment",
"plan",
"that",
"includes",
"regional",
"nodal",
"irradiation"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT02251431 | 1:27:chronic_disease | Collagen vascular diseases | 2 | [
"Collagen",
"vascular",
"diseases"
] | [
2,
2,
2
] |
NCT02573493 | 21:43:treatment | Receiving any other investigational agents | 2 | [
"Receiving",
"any",
"other",
"investigational",
"agents"
] | [
0,
0,
0,
1,
1
] |
NCT02540330 | 27:56:cancer,60:84:cancer,95:105:treatment | Pathological diagnosis of Invasive Ductal Breast Cancer or Ductal Carcinoma in Situ requiring mastectomy | 2 | [
"Pathological",
"diagnosis",
"of",
"Invasive",
"Ductal",
"Breast",
"Cancer",
"or",
"Ductal",
"Carcinoma",
"in",
"Situ",
"requiring",
"mastectomy"
] | [
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
1
] |
NCT02091141 | 1:14:chronic_disease,16:24:chronic_disease,26:38:chronic_disease | Psychological, familial, sociological, or geographical conditions that do not permit compliance with the protocol | 2 | [
"Psychological",
",",
"familial",
",",
"sociological",
",",
"or",
"geographical",
"conditions",
"that",
"do",
"not",
"permit",
"compliance",
"with",
"the",
"protocol"
] | [
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520011 | ,,62:78:chronic_disease,80:89:chronic_disease,94:102:cancer | Have a total bilirubin level ≤2.0 mg/dL (unless secondary to Gilbert syndrome, hemolysis, or leukemia) | 2 | [
"Have",
"a",
"total",
"bilirubin",
"level",
"≤2.0",
"mg/dL",
"(",
"unless",
"secondary",
"to",
"Gilbert",
"syndrome",
",",
"hemolysis",
",",
"or",
"leukemia",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
0,
3,
0
] |
NCT00711373 | 68:83:treatment | severe concomitant diseases which would exclude the recipient from transplantation | 2 | [
"severe",
"concomitant",
"diseases",
"which",
"would",
"exclude",
"the",
"recipient",
"from",
"transplantation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02234934 | 22:56:chronic_disease,60:71:chronic_disease,98:109:chronic_disease,136:139:chronic_disease,141:151:chronic_disease,153:168:chronic_disease,172:185:chronic_disease | No co-infection with Human Immunodeficiency Virus (HIV) or hepatitis B virus (HBsAg positive) or hepatitis C virus (HCV RNA positive), CMV, adenovirus, parvovirus B 19 or toxoplasmosis | 2 | [
"No",
"co-infection",
"with",
"Human",
"Immunodeficiency",
"Virus",
"(",
"HIV",
")",
"or",
"hepatitis",
"B",
"virus",
"(",
"HBsAg",
"positive",
")",
"or",
"hepatitis",
"C",
"virus",
"(",
"HCV",
"RNA",
"positive",
")",
",",
"CMV",
",",
"adenovirus",
",",
... | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
2,
2,
0,
2
] |
NCT02672098 | 43:55:cancer,86:96:cancer,98:125:cancer,130:156:cancer | Histologic types feature would be serous, endometrioid, clear cell, undifferentiated carcinomas, transitional cell carcinoma, or mixed epithelial carcinoma • No End organ function | 2 | [
"Histologic",
"types",
"feature",
"would",
"be",
"serous",
",",
"endometrioid",
",",
"clear",
"cell",
",",
"undifferentiated",
"carcinomas",
",",
"transitional",
"cell",
"carcinoma",
",",
"or",
"mixed",
"epithelial",
"carcinoma",
"•",
"No",
"End",
"organ",
"func... | [
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
3,
0,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0
] |
NCT03063892 | 1:27:chronic_disease | Myocardial infarction (MI) and/or stents within the past year | 2 | [
"Myocardial",
"infarction",
"(",
"MI",
")",
"and/or",
"stents",
"within",
"the",
"past",
"year"
] | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02193373 | 5:27:treatment,,86:120:treatment,122:129:treatment,133:144:treatment | Any manipulative therapies within the previous 7 days (including but not limited to: osteopathic manipulative treatment, massage or acupuncture) | 2 | [
"Any",
"manipulative",
"therapies",
"within",
"the",
"previous",
"7",
"days",
"(",
"including",
"but",
"not",
"limited",
"to",
":",
"osteopathic",
"manipulative",
"treatment",
",",
"massage",
"or",
"acupuncture",
")"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
0
] |
NCT02254863 | 22:34:treatment,36:65:treatment,70:92:treatment | receiving concurrent radiotherapy, immunosuppressive medications, or cytotoxic chemotherapy | 2 | [
"receiving",
"concurrent",
"radiotherapy",
",",
"immunosuppressive",
"medications",
",",
"or",
"cytotoxic",
"chemotherapy"
] | [
0,
0,
1,
0,
1,
1,
0,
0,
1,
1
] |
NCT02832115 | 24:38:treatment | Likely need for use of nitroglycerine for non-study indication | 2 | [
"Likely",
"need",
"for",
"use",
"of",
"nitroglycerine",
"for",
"non-study",
"indication"
] | [
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02429830 | 19:47:chronic_disease,75:84:chronic_disease,86:106:chronic_disease,111:135:chronic_disease,139:155:chronic_disease | Diagnosed with an esophageal motility disorder such as but not limited to achalasia, nutcracker esophagus, or diffuse esophageal spasm or hypertensive LES | 2 | [
"Diagnosed",
"with",
"an",
"esophageal",
"motility",
"disorder",
"such",
"as",
"but",
"not",
"limited",
"to",
"achalasia",
",",
"nutcracker",
"esophagus",
",",
"or",
"diffuse",
"esophageal",
"spasm",
"or",
"hypertensive",
"LES"
] | [
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2
] |
NCT02120222 | 7:34:chronic_disease | other gastrointestinal conditions with increased risk of perforation | 2 | [
"other",
"gastrointestinal",
"conditions",
"with",
"increased",
"risk",
"of",
"perforation"
] | [
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02533882 | 8:23:chronic_disease | Active pressure ulcers | 2 | [
"Active",
"pressure",
"ulcers"
] | [
0,
2,
2
] |
NCT01614990 | 11:26:chronic_disease | untreated thyroid disease | 2 | [
"untreated",
"thyroid",
"disease"
] | [
0,
2,
2
] |
NCT03042767 | 1:41:chronic_disease,65:77:treatment,81:84:treatment | Nonalcoholic fatty liver disease (NAFLD) diagnosis confirmed by liver biopsy or MRI | 2 | [
"Nonalcoholic",
"fatty",
"liver",
"disease",
"(",
"NAFLD",
")",
"diagnosis",
"confirmed",
"by",
"liver",
"biopsy",
"or",
"MRI"
] | [
2,
2,
1,
1,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00739362 | 1:14:chronic_disease,16:25:chronic_disease,34:50:chronic_disease,,, | Liver disease (cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 1.5 times normal) | 2 | [
"Liver",
"disease",
"(",
"cirrhosis",
",",
"active",
"hepatitis",
"B",
"or",
"C",
",",
"and",
"AST",
"or",
"ALT",
"greater",
"than",
"or",
"equal",
"to",
"1.5",
"times",
"normal",
")"
] | [
2,
2,
0,
2,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02833792 | 1:32:treatment | Prior treatment with stem cells | 2 | [
"Prior",
"treatment",
"with",
"stem",
"cells"
] | [
1,
1,
1,
1,
1
] |
NCT01701986 | 1:19:chronic_disease,44:85:chronic_disease,92:99:chronic_disease,101:124:chronic_disease,,, | Active hepatitis B, either active carrier (hepatitis B virus surface antigen [HBsAg] +) or viremic (hepatitis B virus [HBV] deoxyribonucleic acid [DNA] >= 10,000 copies/mL, or >= 2,000 IU/mL) | 2 | [
"Active",
"hepatitis",
"B",
",",
"either",
"active",
"carrier",
"(",
"hepatitis",
"B",
"virus",
"surface",
"antigen",
"[",
"HBsAg",
"]",
"+",
")",
"or",
"viremic",
"(",
"hepatitis",
"B",
"virus",
"[",
"HBV",
"]",
"deoxyribonucleic",
"acid",
"[",
"DNA",
"... | [
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01366612 | 45:60:treatment | Any stage of disease will be considered for transplantation | 2 | [
"Any",
"stage",
"of",
"disease",
"will",
"be",
"considered",
"for",
"transplantation"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02876302 | 24:46:chronic_disease | Clinically significant malabsorption syndrome | 2 | [
"Clinically",
"significant",
"malabsorption",
"syndrome"
] | [
0,
0,
2,
2
] |
NCT01532687 | 5:37:treatment | Any prior treatment with gemcitabine | 2 | [
"Any",
"prior",
"treatment",
"with",
"gemcitabine"
] | [
0,
1,
1,
1,
1
] |
NCT01794559 | 24:50:chronic_disease | primary diagnosis of a DSM-IV depressive disorder | 2 | [
"primary",
"diagnosis",
"of",
"a",
"DSM-IV",
"depressive",
"disorder"
] | [
0,
0,
0,
0,
2,
2,
2
] |
NCT02104349 | 28:41:treatment,53:79:treatment,81:118:treatment,120:141:treatment | Patients that will undergo spine surgery including: single level lumbar fusion, posterior cervical laminectomy fusion, cervical laminaplasty | 2 | [
"Patients",
"that",
"will",
"undergo",
"spine",
"surgery",
"including",
":",
"single",
"level",
"lumbar",
"fusion",
",",
"posterior",
"cervical",
"laminectomy",
"fusion",
",",
"cervical",
"laminaplasty"
] | [
0,
0,
0,
0,
1,
1,
0,
0,
1,
1,
1,
1,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT01989585 | ,84:105:treatment | Left ventricular ejection fraction >= institutional lower limit of normal (LLN) by echocardiogram (ECHO) | 2 | [
"Left",
"ventricular",
"ejection",
"fraction",
">",
"=",
"institutional",
"lower",
"limit",
"of",
"normal",
"(",
"LLN",
")",
"by",
"echocardiogram",
"(",
"ECHO",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0
] |
NCT02208362 | 70:89:chronic_disease | Research participant requires pressor support and/or has symptomatic cardiac arrhythmias | 2 | [
"Research",
"participant",
"requires",
"pressor",
"support",
"and/or",
"has",
"symptomatic",
"cardiac",
"arrhythmias"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02655692 | 14:18:chronic_disease | diagnosis of PTSD | 2 | [
"diagnosis",
"of",
"PTSD"
] | [
0,
0,
2
] |
NCT02437370 | 4:27:treatment | Be previously chemotherapy-treated | 2 | [
"Be",
"previously",
"chemotherapy-treated"
] | [
0,
1,
1
] |
NCT01631617 | 1:18:chronic_disease | Atopic Dermatitis Patients | 2 | [
"Atopic",
"Dermatitis",
"Patients"
] | [
2,
2,
0
] |
NCT02176967 | 30:36:cancer | Patients with MYCN amplified tumors | 2 | [
"Patients",
"with",
"MYCN",
"amplified",
"tumors"
] | [
0,
0,
0,
0,
3
] |
NCT01801072 | 63:69:treatment,71:79:treatment,81:89:treatment,91:99:treatment,101:108:treatment | Currently prescribed medication with anti-epileptic activity (keppra, dilantin, tegretol, lamictal, topamax, etc.) | 2 | [
"Currently",
"prescribed",
"medication",
"with",
"anti-epileptic",
"activity",
"(",
"keppra",
",",
"dilantin",
",",
"tegretol",
",",
"lamictal",
",",
"topamax",
",",
"etc",
".",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0
] |
NCT02366611 | ,,,33:57:cancer,72:100:treatment,104:121:treatment | Patients with AJCC stage III-IV head and neck malignancy scheduled for definitive radiation therapy or chemoradiotherapy | 2 | [
"Patients",
"with",
"AJCC",
"stage",
"III-IV",
"head",
"and",
"neck",
"malignancy",
"scheduled",
"for",
"definitive",
"radiation",
"therapy",
"or",
"chemoradiotherapy"
] | [
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
1,
1,
1,
0,
1
] |
NCT02905370 | 1:14:chronic_disease | Heart Disease | 2 | [
"Heart",
"Disease"
] | [
2,
2
] |
NCT02343042 | 8:28:cancer | Active plasma cell leukemia | 2 | [
"Active",
"plasma",
"cell",
"leukemia"
] | [
0,
3,
3,
3
] |
NCT01742182 | 1:3:chronic_disease,,, | PD Hoehn and Yahr stage 2-4 | 2 | [
"PD",
"Hoehn",
"and",
"Yahr",
"stage",
"2-4"
] | [
2,
0,
0,
0,
0,
0
] |
NCT01626079 | 61:77:treatment | Insufficient mobile leaflet available for grasping with the MitraClip device | 2 | [
"Insufficient",
"mobile",
"leaflet",
"available",
"for",
"grasping",
"with",
"the",
"MitraClip",
"device"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02108860 | 26:38:chronic_disease,68:87:chronic_disease,171:181:treatment,253:256:treatment,266:273:treatment, | Subjects with a positive tuberculosis screening test indicative of latent tuberculosis will be eligible for the study if they have no evidence of current tuberculosis on chest xray at screening and they are actively being treated for tuberculosis with INH or other therapy for latent tuberculosis given according to loca... | 2 | [
"Subjects",
"with",
"a",
"positive",
"tuberculosis",
"screening",
"test",
"indicative",
"of",
"latent",
"tuberculosis",
"will",
"be",
"eligible",
"for",
"the",
"study",
"if",
"they",
"have",
"no",
"evidence",
"of",
"current",
"tuberculosis",
"on",
"chest",
"xray... | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT02519452 | 40:70:treatment | Participant has previously received an allogenic stem cell transplant | 2 | [
"Participant",
"has",
"previously",
"received",
"an",
"allogenic",
"stem",
"cell",
"transplant"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02928991 | 25:34:chronic_disease | negative evaluation for dysplasia | 2 | [
"negative",
"evaluation",
"for",
"dysplasia"
] | [
0,
0,
0,
2
] |
NCT02121158 | 12:20:chronic_disease | documented prior MI | 2 | [
"documented",
"prior",
"MI"
] | [
0,
2,
2
] |
NCT02414269 | 41:53:treatment,55:67:treatment,72:91:treatment, | All acute toxic effects of any previous radiotherapy, chemotherapy, or surgical procedures must have resolved to grade I or lower according to CTCAE (version 4.0) | 2 | [
"All",
"acute",
"toxic",
"effects",
"of",
"any",
"previous",
"radiotherapy",
",",
"chemotherapy",
",",
"or",
"surgical",
"procedures",
"must",
"have",
"resolved",
"to",
"grade",
"I",
"or",
"lower",
"according",
"to",
"CTCAE",
"(",
"version",
"4.0",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02979574 | 1:23:chronic_disease,37:60:treatment,67:87:chronic_disease | Inflammatory arthritis that require disease modifying drugs (e.g. rheumatoid arthritis) | 2 | [
"Inflammatory",
"arthritis",
"that",
"require",
"disease",
"modifying",
"drugs",
"(",
"e.g",
".",
"rheumatoid",
"arthritis",
")"
] | [
2,
2,
0,
0,
1,
1,
1,
0,
0,
0,
2,
2,
0
] |
NCT01175044 | 12:27:allergy_name | Allergy to povidone iodine | 2 | [
"Allergy",
"to",
"povidone",
"iodine"
] | [
0,
0,
4,
4
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.